Phillip Md Et al Frost

Phillip Md Et al Frost has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Opko Health, Inc., Cocrystal Pharma, Inc. and Fluent, Inc. In total, 464 filings cover trades dated from 31 December 2015 to 11 September 2026.

Both buying and selling appear: 445 purchases worth €22.2M, against 1 sale worth €51k. No amount is published for 344 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 share grants and 6 option exercises. 2026 to date brings 5 purchases and no sales.

Half of the purchases are above €40k and half below. Scaled by market value, the purchases weigh a median 0.043% of market cap (sample: 3 purchases). On 20 out of 444 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

On 14 September 2026 came the latest disclosure, a share grant in Nocopi Technologies Inc. The last insider purchase was made public on 6 August 2026, 73 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.